title: Evaluation of liver perfusion in diabetic patients using 99mTc-sestamibi.
abstract: OBJECTIVE
  The liver is an important organ for various aspects of glucose metabolism, including glucose uptake, storage, and synthesis. It is a major organ in the metabolic process with perfusion provided by both the portal vein and hepatic artery. In diabetic patients organ perfusion is reduced and this is linked to atherosclerosis, and as a result complications occur. In this study, we aimed to evaluate liver perfusion by scintigraphic methods in diabetic patients.
  
  
  METHODS
  We retrospectively investigated 1,100 myocardial perfusion scintigraphies taken between January 2011 and December 2012 at Canakkale Onsekiz Mart University Medical Faculty Nuclear Medicine Department. A total of 66 patients who were diagnosed with diabetes mellitus and had myocardial perfusion scintigraphies were included in the study. The control subjects included 127 patients without diabetes mellitus who were chosen at random. Patients with chronic liver disease were not included in the study. The values from liver regions of interest (liver-ROI) rates and heart regions of interest (heart-ROI) rates were compared between the patients and controls.
  
  
  RESULTS
  Patients were grouped according to the presence of diabetes. In the diabetes mellitus group, the liver-ROI average was lower (p = 0.66) than in the controls. In the control group, the average liver-ROI/heart-ROI ratios were higher than the ratio in the diabetes mellitus group (p = 0.019). Multivariate variance analysis showed that the diabetes mellitus liver-ROI/heart-ROI ratio was independent of other risk factors (p = 0.003; F: 9.6). Powered by Editorial Manager(®) and ProduXion Manager(®) from Aries Systems Corporation.
  
  
  CONCLUSIONS
  This study shows that liver perfusion in diabetic patients is reduced compared with those without diabetes. Prospective studies with larger patient groups are required.
authors.affiliation: Department of Internal Medicine, Çanakkale Onsekiz Mart University, Sahil yolu cad., 17100, Çanakkale, Turkey, hcrgrsy@hotmail.com.
authors.forename: Hacer
authors.initials: H
authors.lastname: Şen
authors.forename: Yusuf Ziya
authors.initials: YZ
authors.lastname: Tan
authors.forename: Emine
authors.initials: E
authors.lastname: Binnetoğlu
authors.forename: Mehmet
authors.initials: M
authors.lastname: Aşik
authors.forename: Fahri
authors.initials: F
authors.lastname: Güneş
authors.forename: Gökhan
authors.initials: G
authors.lastname: Erbağ
authors.forename: Emine
authors.initials: E
authors.lastname: Gazi
authors.forename: Sibel
authors.initials: S
authors.lastname: Cevizci
authors.forename: Semra
authors.initials: S
authors.lastname: Özdemir
authors.forename: Erdem
authors.initials: E
authors.lastname: Akbal
authors.forename: Kubilay
authors.initials: K
authors.lastname: Ükinç
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity; D003920:Diabetes Mellitus / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008099:Liver / Q000098:blood supply / Q000000981:diagnostic imaging / Q000503:physiopathology*; D008102:Liver Circulation; D008297:Male; D008875:Middle Aged; D055414:Myocardial Perfusion Imaging / Q000379:methods; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi